Using speech analysis to detect changes in people with Parkinson's disease
Tests whether computer analysis of speech can detect movement, mood and thinking changes in Parkinson's.
Plain-language title generated from the registry record
Registry title: SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's Disease
Key facts
- Where
- Bern, SwitzerlandSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 75 years old?
Source: NCT05765110, who can take part
Where in Switzerland
- University Hospital Inselspital, BerneBern, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Insel Gruppe AG, University Hospital Bern
- Trial code
- NCT05765110
- Record updated
- 22 May 2026
- Original description
With this study, the investigators want to investigate whether computerized speech analysis can be used to reliably and objectively detect motor, emotional, and cognitive fluctuations in Parkinson's disease patients.Read full original descriptionShow less
SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's Disease
With this study, the investigators want to investigate whether computerized speech analysis can be used to reliably and objectively detect motor, emotional, and cognitive fluctuations in Parkinson's disease patients.
Inclusion: Written informed consent; Idiopathic PD according to the Movement Disorders Society Criteria; Age of participants > 30 and ≤ 75 years; Treatment with or without bilateral deep brain stimulation in the subthalamic nucleus; Fluent in German or French; Written informed consent; Adults from 50-70 years old; Fluent in German or French.
Exclusion: Dysarthria caused in addition by a condition other than PD (e.g. stroke, myasthenia); Brain disease other than Parkinson's disease (e.g. atypical Parkinsonism, Alzheimer's disease, vascular dementia, multiple sclerosis, stroke, traumatic brain injury, epilepsy, etc.); Cognitive impairment (Montreal Cognitive Assessment (MoCa) < 24/30 points); Diagnosis of Parkinson's disease; Cognitive impairment (Montreal Cognitive Assessment (MoCa) < 24/30 points); Suffering from brain disease (e.g. atypical Parkinsonism, Alzheimer's disease, vascular dementia, multiple sclerosis, stroke, traumatic brain injury, epilepsy, etc.); Suffering from or diagnosed with psychiatric illnesses according to DSM-V criteria; Clinical diagnosis of aphasia; Depression with acute suicidal ideation; Healthy Controls; Clinical diagnosis of aphasia, dysarthria, and stuttering.
Patients with Parkinson's Disease.